Aquestive Therapeutics, Inc. Depreciation
Aquestive Therapeutics, Inc. (AQST) reported Depreciation of $136.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Aquestive Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $136.00K, a 2.86% decline year-over-year.
- Aquestive Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $113.00K, a 18.71% decline year-over-year.
- Aquestive Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $130.00K, a 11.56% decline year-over-year.
- Aquestive Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $139.00K, a 12.58% decline year-over-year.
- Aquestive Therapeutics, Inc. depreciation for fiscal 2025 was $548.00K, a 14.38% decline from fiscal 2024.
- Aquestive Therapeutics, Inc. depreciation for fiscal 2024 was $640.00K, a 44.49% decline from fiscal 2023.
- Aquestive Therapeutics, Inc. depreciation for fiscal 2023 was $1.15M, a 49.21% decline from fiscal 2022.
- Aquestive Therapeutics, Inc. depreciation for fiscal 2022 was $2.27M, a 22.05% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $136.00K 10-Q · filed 2026-08-11 | $249.00K 10-Q · filed 2026-08-11 | $379.00K derived: sum of 3 quarters · filed 2026-08-11 | $518.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $113.00K 10-Q · filed 2026-05-13 | $243.00K derived: sum of 2 quarters · filed 2026-05-13 | $382.00K derived: sum of 3 quarters · filed 2026-05-13 | $522.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $269.00K derived: sum of 2 quarters · filed 2026-03-04 | $409.00K derived: sum of 3 quarters · filed 2026-08-11 | $548.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $139.00K 10-Q · filed 2025-11-05 | $279.00K derived: sum of 2 quarters · filed 2026-08-11 | $418.00K 10-Q · filed 2025-11-05 | $565.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $140.00K 10-Q · filed 2026-08-11 | $279.00K 10-Q · filed 2026-08-11 | $426.00K derived: sum of 3 quarters · filed 2026-08-11 | $585.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $139.00K 10-Q · filed 2026-05-13 | $286.00K derived: sum of 2 quarters · filed 2026-05-13 | $445.00K derived: sum of 3 quarters · filed 2026-05-13 | $610.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $306.00K derived: sum of 2 quarters · filed 2026-03-04 | $471.00K derived: sum of 3 quarters · filed 2026-03-04 | $640.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $159.00K 10-Q · filed 2025-11-05 | $324.00K derived: sum of 2 quarters · filed 2025-11-05 | $493.00K 10-Q · filed 2025-11-05 | $885.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $165.00K 10-Q · filed 2025-08-11 | $333.00K 10-Q · filed 2025-08-11 | $726.00K derived: sum of 3 quarters · filed 2025-08-11 | $944.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $168.00K 10-Q · filed 2025-05-12 | $561.00K derived: sum of 2 quarters · filed 2025-05-12 | $779.00K derived: sum of 3 quarters · filed 2025-05-12 | $1.03M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $611.00K derived: sum of 2 quarters · filed 2025-03-05 | $861.00K derived: sum of 3 quarters · filed 2025-03-05 | $1.15M 10-K · filed 2025-03-05 |
| 2023-09-30 | $218.00K 10-Q · filed 2024-11-04 | $468.00K derived: sum of 2 quarters · filed 2024-11-04 | $760.00K 10-Q · filed 2024-11-04 | $1.10M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $250.00K 10-Q · filed 2024-08-06 | $536.00K 10-Q · filed 2024-08-06 | $880.00K derived: sum of 3 quarters · filed 2024-08-06 | $1.44M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $286.00K 10-Q · filed 2024-05-07 | $630.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.19M derived: sum of 3 quarters · filed 2024-05-07 | $1.84M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $901.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.56M derived: sum of 3 quarters · filed 2024-03-05 | $2.27M 10-K · filed 2024-03-05 |
| 2022-09-30 | $557.00K 10-Q · filed 2023-11-06 | $1.21M derived: sum of 2 quarters · filed 2023-11-06 | $1.93M 10-Q · filed 2023-11-06 | $2.64M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $655.00K 10-Q · filed 2023-08-07 | $1.37M 10-Q · filed 2023-08-07 | $2.09M derived: sum of 3 quarters · filed 2023-08-07 | $2.81M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $714.00K 10-Q · filed 2023-05-02 | $1.43M derived: sum of 2 quarters · filed 2023-05-02 | $2.15M derived: sum of 3 quarters · filed 2023-05-02 | $2.88M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.44M derived: sum of 2 quarters · filed 2023-03-31 | $2.17M derived: sum of 3 quarters · filed 2023-03-31 | $2.91M 10-K · filed 2023-03-31 |
| 2021-09-30 | $724.00K 10-Q · filed 2022-11-01 | $1.45M derived: sum of 2 quarters · filed 2022-11-01 | $2.19M 10-Q · filed 2022-11-01 | $3.46M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $728.00K 10-Q · filed 2022-08-02 | $1.47M 10-Q · filed 2022-08-02 | $2.74M derived: sum of 3 quarters · filed 2022-08-02 | $3.45M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $743.00K 10-Q · filed 2022-05-04 | $2.01M derived: sum of 2 quarters · filed 2022-05-04 | $2.72M derived: sum of 3 quarters · filed 2022-05-04 | $3.42M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.98M derived: sum of 2 quarters · filed 2022-03-08 | $2.68M derived: sum of 3 quarters · filed 2022-03-08 | $3.39M 10-K · filed 2022-03-08 |
| 2020-09-30 | $714.00K 10-Q · filed 2021-11-02 | $1.41M derived: sum of 2 quarters · filed 2021-11-02 | $2.13M 10-Q · filed 2021-11-02 | $2.84M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $700.00K 10-Q · filed 2021-08-03 | $1.41M 10-Q · filed 2021-08-03 | $2.13M derived: sum of 3 quarters · filed 2021-08-03 | $2.82M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $714.00K 10-Q · filed 2021-05-04 | $1.43M derived: sum of 2 quarters · filed 2021-05-04 | $2.12M derived: sum of 3 quarters · filed 2021-05-04 | $2.83M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $1.41M derived: sum of 2 quarters · filed 2021-03-09 | $2.12M derived: sum of 3 quarters · filed 2021-03-09 | $2.85M 10-K · filed 2021-03-09 |
| 2019-09-30 | $695.00K 10-Q · filed 2020-11-04 | $1.41M derived: sum of 2 quarters · filed 2020-11-04 | $2.14M 10-Q · filed 2020-11-04 | $2.89M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $711.00K 10-Q · filed 2020-08-04 | $1.45M 10-Q · filed 2020-08-04 | $2.19M derived: sum of 3 quarters · filed 2020-08-04 | $2.93M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $736.00K 10-Q · filed 2020-05-05 | $1.48M derived: sum of 2 quarters · filed 2020-05-05 | $2.22M derived: sum of 3 quarters · filed 2020-05-05 | $2.98M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $1.48M derived: sum of 2 quarters · filed 2020-03-11 | $2.25M derived: sum of 3 quarters · filed 2020-03-11 | $3.19M 10-K · filed 2020-03-11 |
| 2018-09-30 | $733.00K 10-Q · filed 2019-11-05 | $1.50M derived: sum of 2 quarters · filed 2019-11-05 | $2.44M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $765.00K 10-Q · filed 2019-08-06 | $1.71M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $940.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |